GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDL Biotech AB (XSAT:IDL) » Definitions » Median PS Value

IDL Biotech AB (XSAT:IDL) Median PS Value : kr0.74 (As of May. 25, 2024)


View and export this data going back to 2004. Start your Free Trial

What is IDL Biotech AB Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. IDL Biotech AB's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2021 was kr0.311. IDL Biotech AB's 10-Year median PS Ratio is 2.3794. Therefore, the Median PS Value for today is kr0.74.

As of today (2024-05-25), IDL Biotech AB's share price is kr2.88. IDL Biotech AB's Median PS Value is kr0.74. Therefore, IDL Biotech AB's Price to Median PS Value for today is 3.89.

The historical rank and industry rank for IDL Biotech AB's Median PS Value or its related term are showing as below:

XSAT:IDL' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 1.49   Med: 2.57   Max: 5
Current: 3.89

During the past 13 years, the highest Price to Median PS Value of IDL Biotech AB was 5.00. The lowest was 1.49. And the median was 2.57.

XSAT:IDL's Price-to-Median-PS-Value is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 0.81 vs XSAT:IDL: 3.89

IDL Biotech AB Median PS Value Historical Data

The historical data trend for IDL Biotech AB's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDL Biotech AB Median PS Value Chart

IDL Biotech AB Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 1.50 0.90 0.77

IDL Biotech AB Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.87 0.81 0.77 0.67 0.74

Competitive Comparison of IDL Biotech AB's Median PS Value

For the Diagnostics & Research subindustry, IDL Biotech AB's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDL Biotech AB's Price-to-Median-PS-Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDL Biotech AB's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where IDL Biotech AB's Price-to-Median-PS-Value falls into.



IDL Biotech AB Median PS Value Calculation

IDL Biotech AB's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=0.311*2.3794
=0.74

10-Year Median PS Ratio is 2.3794.
IDL Biotech AB's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.311.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IDL Biotech AB  (XSAT:IDL) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

IDL Biotech AB's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=2.88/0.74
=3.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IDL Biotech AB Median PS Value Related Terms

Thank you for viewing the detailed overview of IDL Biotech AB's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


IDL Biotech AB (XSAT:IDL) Business Description

Traded in Other Exchanges
N/A
Address
Karlsbodavagen 39, Stockholm, SWE
IDL Biotech AB develops, produces and markets In Vitro Diagnostic tests for the health care sector. It offers in vitro diagnostic tests within the clinical areas of oncology and bacteriology. The company's trademark products includes TUBEX, TPS, UBC, MonoTotal and TPAcyk.

IDL Biotech AB (XSAT:IDL) Headlines

No Headlines